Operational definitions of sarcopenia should consider depressive symptoms
JCSM Clinical Reports · 2021
DOI: 10.1002/crt2.32 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCSM Clinical Reports, 2021. Verfasst von Julie A. Pasco und 7 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Themen: Depression
Abstract (Originalsprache)
Background
Originally, sarcopenia meant ‘poverty of flesh’, but recent operational definitions have brought poor muscle function to the fore. None has considered psychological well‐being. We compared muscle function components of the European Working Group on Sarcopenia in Older People Version 2 (EWGSOP2), the Foundation for the National Institutes of Health (FNIH), and the Sarcopenia Definitions and Outcomes Consortium (SDOC) algorithms for individuals with and without depressive and anxiety symptoms.
Methods
This cross‐sectional study involved 348 women and 343 men (ages 60–96 years) from the Geelong Osteoporosis Study. Hospital Anxiety and Depression Scale scores for depression and anxiety ≥8 indicated depressive and anxiety symptoms. Measures included handgrip strength (HGS) and Timed Up and Go (TUG). Chi‐squared test identified inter‐group differences, and multivariable logistic regression identified poor muscle function in association with depressive or anxiety symptoms.
Results
Twenty‐nine (8.3%) women and 28 (8.2%) men had depressive symptoms, and 83 (23.9%) women and 41 (12.0%) men had anxiety symptoms. For women, proportions with low HGS were greater for those with vs. without depressive symptoms according to EWGSOP2 and FNIH (37.9% vs. 10.7%) and SDOC (51.7% vs. 26.7%); low HGS/body mass index (44.8% vs. 15.7%); and slow TUG (12.5% vs. 1.4%) (all P ≤ 0.011). In age‐adjusted models, women with depressive symptoms were two‐fold to five‐fold more likely to have low HGS by EWGSOP2 and FNIH {odds ratio [OR] 4.77 [95% confidence interval (CI) 1.83–12.45]} and SDOC [OR 2.59 (95% CI 1.10–6.07)], low HGS/body mass index [OR 3.92 (95% CI 1.69–9.07)], and 11‐fold more likely to have a slow TUG [OR 10.99 (95% CI 2.03–59.7)]. For men, a difference for low HGS for those with depressive symptoms was detected only for SDOC (64.3% vs. 40.0%, P = 0.013), but this was explained by age [OR 1.99 (95% CI 0.84–4.71)]. No differences were detected for anxiety symptoms.
Conclusions
Operational definitions should consider depressive symptoms, at least in women, at the time of muscle function evaluation.
Förderung
- National Health and Medical Research Council
Zitieren
APA
Pasco, J. A., Sui, S. X., West, E. C., Holloway‐Kew, K. L., Hyde, N. K., Stuart, A. L., Gaston, J., & Williams, L. J. (2021). Operational definitions of sarcopenia should consider depressive symptoms. JCSM Clinical Reports. https://doi.org/10.1002/crt2.32
Vancouver
Pasco JA, Sui SX, West EC, Holloway‐Kew KL, Hyde NK, Stuart AL, et al. Operational definitions of sarcopenia should consider depressive symptoms. JCSM Clinical Reports. 2021. doi:10.1002/crt2.32
BibTeX
@article{Pasco2021,
author = {Pasco, Julie A. and Sui, Sophia X. and West, Emma C. and Holloway‐Kew, Kara L. and Hyde, Natalie K. and Stuart, Amanda L. and Gaston, James and Williams, Lana J.},
title = {Operational definitions of sarcopenia should consider depressive symptoms},
journal = {JCSM Clinical Reports},
year = {2021},
doi = {10.1002/crt2.32}
}
EUVIMED